Symptoms of Multisystem Inflammatory Syndrome in Children (MIS-C)
The primary symptoms of MIS-C include persistent fever (≥38.0°C for ≥24 hours or ≥3 days), gastrointestinal manifestations (abdominal pain, diarrhea, vomiting), mucocutaneous findings (rash, conjunctivitis, red/cracked lips, strawberry tongue), and cardiovascular involvement often progressing to shock. 1
Core Clinical Features
Cardinal Symptoms (Present in Most Cases)
- Fever: Present in nearly 100% of cases 2
- Gastrointestinal symptoms (77-94% of cases):
- Mucocutaneous manifestations (63-68% of cases):
- Polymorphic rash (maculopapular or petechial, not vesicular)
- Bilateral conjunctivitis (without exudate)
- Red/cracked lips
- Strawberry tongue
- Erythema of oropharyngeal mucosa
- Swollen hands and feet 1
Common Additional Symptoms
- Headache (68%) 3
- Lymphadenopathy (especially cervical) 1
- Neck swelling 1
- Sore throat 1
- Syncope 1
- Confusion or altered mental status 1
Organ System Involvement
Cardiovascular (Very Common)
- Myocardial dysfunction (40-53% of cases)
- Pericarditis (20%)
- Coronary artery abnormalities (13%)
- Shock (14-23% requiring intensive care) 2, 3
- Elevated cardiac markers (troponin in 41%, NT-pro-BNP in 50%) 2
Respiratory
- Respiratory symptoms in 28% of cases 4
- Cough 1
- Respiratory distress (less common than in acute COVID-19) 4
Neurological
- Headache
- Altered mental status
- Encephalopathy
- Focal neurologic deficits
- Meningismus
- Seizures (10.5%) 3
- Papilledema 1
Renal
- Acute kidney injury (26%) 3
Hematologic
- Lymphopenia (84%)
- Thrombocytopenia (37%) 3
Laboratory Findings
Inflammatory Markers (Markedly Elevated)
- C-reactive protein (CRP) >10 mg/dL (often >15 mg/dL)
- Elevated erythrocyte sedimentation rate (ESR)
- Elevated ferritin
- Elevated procalcitonin
- Elevated D-dimer
- Elevated IL-6 1
Other Laboratory Abnormalities
- Neutrophilia
- Lymphopenia
- Hypoalbuminemia
- Hyponatremia (Na <135 mmol/L)
- Elevated liver enzymes 1
Warning Signs Requiring Immediate Medical Attention
- Abnormal vital signs (tachycardia, tachypnea)
- Respiratory distress of any severity
- Neurologic deficits or changes in mental status (even subtle)
- Evidence of renal or hepatic injury
- Marked elevations in inflammation markers (CRP >10 mg/dL)
- Abnormal EKG or elevated cardiac markers 1
Distinguishing Features from Kawasaki Disease
MIS-C differs from Kawasaki Disease in several important ways:
- Affects a broader age range (median age 8-12 years vs. typically <5 years for KD)
- More prominent gastrointestinal and neurologic symptoms
- Higher likelihood of shock and cardiac dysfunction
- Lower platelet counts and lymphocyte counts
- Higher CRP levels
- Higher incidence in children of African, Afro-Caribbean, and Hispanic descent 1
Timing and Association with COVID-19
MIS-C typically develops 2-6 weeks after SARS-CoV-2 infection, often after the acute infection has resolved 1. This temporal association is critical for diagnosis, as many patients may have negative PCR tests but positive serology for SARS-CoV-2 1.
Remember that MIS-C is a rare but serious complication of SARS-CoV-2 infection, with an estimated incidence of 0.69 per 1,000 SARS-CoV-2 infections 2. Early recognition of these symptoms and prompt medical attention are essential for reducing morbidity and mortality.